Pressure Biosciences's total assets for Q2 2024 were $6.88B, an increase of 98294.89% from the previous quarter. PBIO total liabilities were $44.11B for the fiscal quarter, a 97659.44% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.